This website is for Australian audiences only

Welcome to
Special Exhibits

Delve into exhibits that explore the latest science on topics related to rheumatic diseases

Explore the role of the IL-17 family in disease

The IL-17 family of cytokines consists of 6 structurally related signaling molecules (IL-17A, IL-17B, IL-17C, IL-17D, IL-17E, and IL-17F) that play important roles in the immune system.1 Tour an exhibit that examines each of these cytokines and their role in SpA and other immune-mediated inflammatory diseases.

Tour the IL-17 exhibit

Investigate the relationship between IBD and arthritis

IBD-associated arthritis has complex manifestations that can significantly impact a patient’s quality of life. This exhibit explores the clinical manifestations, pathobiology, and burden of disease relating to IBD-SpA, and the importance of multidisciplinary collaboration.

IBD=inflammatory bowel disease.

Tour the IBD-SpA exhibit

  1. Brembilla NC, Senra L, Boehncke WH. The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front Immunol. 2018;9:1682. doi: 10.3389/fimmu.2018.01682

The information provided is intended to inform and does not replace the advice of your healthcare professional. For any questions regarding inflammatory arthritis and its treatment, please talk to your healthcare professional.

This website is not intended for reporting of adverse events or product complaints regarding UCB products. If you think you may be experiencing a side effect after using a medicine, seek advice from a healthcare professional as soon as possible.

If you wish to report an adverse event or product complaint regarding a UCB product, you can contact UCB Australia via ucbcares.au@ucb.com or phone 03 9828 1800 (Option 3). Alternatively, you may report information on adverse events directly to the TGA at https://www.tga.gov.au/safety/reporting-problems.

© 2025 UCB Australia Pty Ltd. (ABN 48 005 799 208). Level 1, 1155 Malvern Rd. Malvern VIC 3144, Australia.
Telephone: +61 (3) 9828 1800. Facsimile: +61 (3) 9828 1860. February 2025. AU-DA-2400137

Exiting RheuMuseum?

The information you are about to be referred to may not comply with the Australian regulatory environment. Please refer to the Product Information or Consumer Medicines Information for products to fully understand the terms of a product’s registration in Australia.

The intent of providing this material is informational and not as advice.

Any information provided by this source should be discussed with your healthcare professional and does not replace their advice.

OK